Atlas Trials

A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra

Clinical trial NCT03224598 · COMPLETED

Trial details

NCT number
NCT03224598
Sponsor
Aclaris Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dermatosis Papulosa Nigra
Start date
2017-06-26
Primary completion
2019-01-08
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.